Sounds like a bit of back pedal to me there Doc. Took your time on Sunday too. NA as a control. Why ? It is not standard of care. If we going to have multiple control groups perhaps just the usual cortisone injection . But if I was a trial participant I would be very peed off , bad enough having only a 50% chance of receiving the good cells.
Perhaps we could terminate the control group early say at 3 months, note how flat the results for the control are at 3 months onwards . That would mean that every one would get treatment.
Depending on how consent the results of individuals that have been treated in the last trial we may be able to also split that group in the confirmatory trial at 3 and or 6 months for a second treatment .
This would answer the question
Would a second treatment be useful ?
Ann: 36-Month Results of Phase 3 Trial in Chronic Low Back Pain, page-181
-
- There are more pages in this discussion • 193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.5¢ |
Change
0.020(2.26%) |
Mkt cap ! $1.033B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 95.0¢ | 88.0¢ | $5.610M | 6.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 317774 | 90.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 23500 | 2 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |